Home

Rekha Hemrajani

CIK 1771213 · President and CEO · last filed 2026-06-22

Rekha Hemrajani is a President and CEO who has filed 30 SEC Form 4 insider transactions across 7 companies since 2019. The most recent filing, for MXCT, was dated Jun 22, 2026. Across all open-market trades the lifetime net is +$135.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $205.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$205.3K

Companies

7

Total Filings

30

Lifetime Open-Market Net

$135.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MXCT Director 70,314 $1.05 $73.8K -$22.4K 8 2026-06-22
BIOA Director 3,000 $21.92 $65.8K $54.0K 4 2026-06-12
LBRX Director — $34.94 — $0 2 2026-06-05
ALXO Director 33,000 $1.99 $65.7K $103.4K 8 2026-01-21
Adverum Biotechnologies, Inc. (ADVM) Delisted Director — $4.36 — $0 4 2020-06-25
Aravive, Inc. (ARAV) Delisted President and CEO 14,250 $0.04 $571 $0 2 2020-04-09
RCUS See Remarks — $27.05 — $0 1 2019-03-25

Recent Filings

30 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 MXCT Grant (A) +30,421 $0 EDGAR
2026-06-12 BIOA Grant (A) — $0 EDGAR
2026-06-05 LBRX Grant (A) — $0 EDGAR
2026-01-21 ALXO Grant (A) — $0 EDGAR
2025-09-12 LBRX Grant (A) — $0 EDGAR
2025-08-27 MXCT Sell (S) −10,684 -$22.4K EDGAR
2025-06-25 MXCT Notice (144) −10,684 -$22.4K EDGAR
2025-06-23 MXCT Grant (A) +29,210 $0 EDGAR
2025-06-09 BIOA Grant (A) — $0 EDGAR
2025-03-10 BIOA Buy (P) +3,000 $54.0K EDGAR
Showing 1–10 of 30
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.